Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S2215-0366(24)00062-2 | DOI Listing |
Basic Res Cardiol
September 2024
Cardio-Oncology Unit, Cardiology Department, La Paz University Hospital, IdiPAZ Research Institute, C/ Paseo de la Castellana nº 261, 28046, Madrid, Spain.
Lancet Psychiatry
May 2024
Department of Psychiatry and Psychotherapy, University Psychiatric Clinics, University of Basel, Basel 4002, Switzerland. Electronic address:
Eur Heart J Cardiovasc Imaging
October 2023
William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom.
Eur Heart J
December 2023
William Harvey Research Institute, Queen Mary University of London,Charterhouse Square, London EC1M 6BQ, United Kingdom.
Europace
August 2023
Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, via del Pozzo 71, 41125 Modena, Italy.
Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of this common arrhythmia. Substantial advances in the epidemiology and associated pathophysiology underlying AF-related stroke and thrombo-embolism are evident. Furthermore, the introduction of the non-vitamin K antagonist oral anticoagulants (also called direct oral anticoagulants) has clearly changed our approach to stroke prevention in AF, such that the default should be to offer oral anticoagulation for stroke prevention, unless the patient is at low risk.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!